尼妥珠单抗联合调强放疗与单纯放疗治疗局部晚期鼻咽癌的效果比较

Abstract
Figure/Table
References (16)
Related Citation (15)

Download: PDF (0 KB) HTML (31 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the effect between Nimotuzumab combined with intensity-modulated radiotherapy(IMRT)and radiotherapy alone in the treatment of locally advanced nasopharyngeal carcinoma.Methods A total of 100 patients with locally advanced nasopharyngeal carcinoma who were admitted to Anshan Cancer Hospital from April 2015 to April 2017 were selected as the research subjects,and they were divided into the control group(50 cases)and the intervention group(50 cases)according to the random lottery method.Patients in the control group received IMRT alone,and patients in the intervention group were treated with Nimotuzumab for targeted therapy on the basis of IMRT.The therapeutic effect,survival period(overall survival [OS],progression-free survival [PFS]),quality of life,and incidence of adverse reactions were compared between the two groups.Results The total effective rate and disease control rate of the intervention group were higher than those of the control group,and the differences were statistically significant(P＜0.05).The OS and PFS of the intervention group were longer than those of the control group,and the quality of life score was higher than that of the control group,the differences were statistically significant(P＜0.05).The total incidence of adverse reactions in the intervention group was lower than that in the control group,and the difference was statistically significant(P＜0.05).Conclusion The effect of Nimotuzumab combined with IMRT is significantly better than that of radiotherapy alone in the treatment of locally advanced nasopharyngeal carcinoma.It can improve the local control rate,improve the quality of life of patients,and prolong their survival.It is worthy of popularization and application.

Key words： Nimotuzumab Intensity-modulated radiotherapy Radiotherapy alone Nasopharyngeal carcinoma

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	ZHANG Xiao-xiao

Cite this article:

ZHANG Xiao-xiao. Effect comparison between Nimotuzumab combined with intensity-modulated radiotherapy and radiotherapy alone in the treatment of locally advanced nasopharyngeal carcinoma[J]. 中国当代医药, 2021, 28(13): 166-168-172.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2021/V28/I13/166

[1]	苏建淳，张国义，卢秋霞，等.同步放化疗vs 尼妥珠单抗联合放疗治疗老年晚期鼻咽癌的临床效果、安全性及远期生存率分析[J].心血管外科杂志（电子版），2017，6（3）：264-265.
[2]	王新森.尼妥珠单抗联合奈达铂同期三维适形放疗治疗局部晚期鼻咽癌疗效分析[J].肿瘤基础与临床，2017，30（4）：325-327.
[3]	郑崴，邱素芳，许元基，等.尼妥珠单抗联合调强放疗及化学治疗在局部晚期鼻咽癌的近期疗效观察[J].中国医药科学，2014，4（22）：7-9，12.
[4]	林俞丞，郭立兵，林王美.尼妥珠单抗联合放化疗治疗晚期鼻咽癌的临床疗效分析[J].中国实用医药，2017，12（17）：138-139.
[5]	彭政，李文峰.尼妥珠单抗联合调强适形放疗治疗晚期局部鼻咽癌临床疗效及预后分析[J].中国基层医药，2017，24（11）：1727-1731.
[6]	钟琼，刘建生，吴仁瑞.尼妥珠单抗联合放疗治疗复发转移性鼻咽癌的临床研究[J].当代医学，2017，23（11）：40-42.
[7]	贾桂英.尼妥珠单抗联合适形放化疗对局部晚期鼻咽癌的疗效[J].实用临床医学，2017，18（2）：12-13.
[8]	舒禹先.顺铂和5-氟脲嘧啶联合尼妥珠单抗作为一线方案治疗转移鼻咽癌的临床观察[J].实用癌症杂志，2016，31（12）：2090-2092.
[9]	刘少平，钱文军.尼妥珠单抗联合多西他赛和顺铂治疗中晚期鼻咽癌的临床研究[J].肿瘤基础与临床，2016，29（6）：493-495.
[10]	廖希一，孔琳，郑华，等.局部晚期鼻咽癌放疗联合顺铂或尼妥珠单抗的疗效比较[J].中华放射肿瘤学杂志，2016，25（12）：1277-1280.
[11]	赵梁桦，宾三梅，陈紫云.尼妥珠单抗联合放疗治疗晚期鼻咽癌患者的护理[J].黑龙江医学，2016，40（11）：1061-1062.
[12]	廖家华，许明君，王钇力，等.尼妥珠单抗联合适形放疗及化疗治疗局部晚期鼻咽癌的临床应用效果观察[J].药品评价，2016，13（21）：35-37，56.
[13]	庄文杰，柳春晖，司徒慧如，等.老年中晚期鼻咽癌患者尼妥珠单抗联合顺铂及5-氟尿嘧啶放化疗的临床研究[J].老年医学与保健，2016，22（5）：309-312.
[14]	王方正，蒋春儿，叶智敏，等.长疗程尼妥珠单抗联合放化疗治疗局部晚期鼻咽癌的可行性[J].中国肿瘤生物治疗杂志，2016，23（5）：692-697.
[15]	石兴源，艾亮梅，黄文瑾，等.尼妥珠单抗联合顺铂同期化疗治疗局部晚期鼻咽癌疗效[J].广州医科大学学报，2016，44（5）：42-47.
[16]	蔡传书，王培荣，柯春林.卡培他滨联合尼妥珠单抗治疗局部晚期鼻咽癌的临床研究[J].中国临床药理学杂志，2016，32（15）：1393-1395.